Industry News
In Stage I Non-Small Cell Lung Cancer Patients, SUVmax Provides Valuable Indicator Of Progression-Free Survival
Feb 12, 2013
SUVmax (Maximum Standardized Uptake Value) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT), according to research presented at the 2013 Cancer Imaging and Radiation Therapy Symposium... Read More
Rooting Out Recurrent Breast Cancer
Feb 12, 2013
Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy... Read More
Epigenetic Investigation Of Mice Can Contribute To Early Diagnosis Of Cancer In Humans
Feb 12, 2013
Tumourigenesis is driven by genetic alterations and by changes in the epigenome, for instance by the addition of methyl groups to cytosine bases in the DNA. A deeper understanding of the interaction between the genetic and epigenetic mechanisms is critical for the selection of tumour biomarkers and for the future development of therapies... Read More
12 Important Warning Signs Of Complications In Colorectal Surgical Patients Put Forth By A Panel Of Surgical Experts
Feb 12, 2013
Colorectal surgical patients are often discharged from the hospital with vague guidance on how to recognize complications, but researchers at the Michael DeBakey Veterans Administration (VA) Medical Center and Baylor College of Medicine, Houston, aim to change that scenario... Read More
Exercise Reduces Prostate Cancer Risk In White Men
Feb 12, 2013
Exercise reduces the risk of prostate cancer in white men. Working out can also lower the chance of developing more severe forms of the cancer in Caucasian males who have the disease. However, African-American men do not experience the same advantages from exercising... Read More
Marrying Genome-wide And Proteome-wide Screening Helps Determine Susceptibility In A Wide Variety Of Diseases
Feb 12, 2013
For the first time, scientists have combined genomic and proteomic analysis of blood plasma to enhance identification of genetically regulated protein traits. This could be applied to any large association study of civilization diseases where blood plasma has been collected, vastly improving a clinician's ability to identify disease susceptibility in individuals and populations... Read More
Exercise Reduces Prostate Cancer Risk In White Men
Feb 12, 2013
Exercise reduces the risk of prostate cancer in white men. Working out can also lower the chance of developing more severe forms of the cancer in Caucasian males who have the disease. However, African-American men do not experience the same advantages from exercising... Read More
Epigenetic Investigation Of Mice Can Contribute To Early Diagnosis Of Cancer In Humans
Feb 12, 2013
Tumourigenesis is driven by genetic alterations and by changes in the epigenome, for instance by the addition of methyl groups to cytosine bases in the DNA. A deeper understanding of the interaction between the genetic and epigenetic mechanisms is critical for the selection of tumour biomarkers and for the future development of therapies... Read More
12 Important Warning Signs Of Complications In Colorectal Surgical Patients Put Forth By A Panel Of Surgical Experts
Feb 12, 2013
Colorectal surgical patients are often discharged from the hospital with vague guidance on how to recognize complications, but researchers at the Michael DeBakey Veterans Administration (VA) Medical Center and Baylor College of Medicine, Houston, aim to change that scenario... Read More
Trial Compares Ways To Elicit Patient Values About Prostate-Specific Antigen Screening
Feb 11, 2013
Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening... Read More
Previous Page Next Page